Advanced Wound Dressing Market Segmentation By Product( Hydrogels Dressings, Semi-Permeable Films Dressings, Alginate Dressings, Foam Dressings, Hydrocolloid Dressings, Collagen Dressing, Contact Layer, Super Absorbent Dressings, Hydrofibres)
Industry: Healthcare
Published Date: January-2023
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 324
Report ID: PMRREP31673
The global revenue from the advanced wound dressing market was approximately US$ 6020.5 Million in 2022, with the global market expected to grow at a CAGR of 3.4% to reach a valuation of approximately US$ 8730.6 Million by the end of 2033.
|
Market Size (2023) |
US$ 6220.1 Million |
|
Projected Market Value (2033) |
US$ 8730.6 Million |
|
Global Market Growth Rate (2023-2033) |
3.4% CAGR |
|
Market Share of Top 5 Countries |
60.6% |
As assessed by Persistence Market Research, foam dressings held a market share of around 27.2% in the global market, in 2022. Overall, advanced wound dressing market sales account for approximately 28.90% revenue share in the global wound care market, which was valued at around US$ 20845.23 Million in 2022.
The global market recorded a historic CAGR of 3.4% in the last 5 years from 2015 to 2022.
A large number of interdependent elements influence critical events during the physiological process of wound healing. Although the majority of superficial wounds heal normally, occasionally they seem to not, which can result in infection and/or chronic wounds. The management of wounds is a serious global concern that puts a heavy cost on patients and healthcare systems.
Over the past fifty years, there have been major advancements in the care of wounds because of better understanding of the wound healing process and technological advancements. These include advanced textiles with antimicrobial functionality made of materials with inherent bactericidal activity, modified surfaces, or integrated antimicrobial agents, as well as smart systems like bioactive dressings to promote wound healing.
An ideal extracellular environment and coordination among many cell types are required for the dynamic process of wound healing. Finding better ways to treat and manage common medical issues like sepsis, burn injuries, chronic injuries, and skin injuries has been a major emphasis of research. Designing multifunctional dressings is a new research strategy to enhance natural healing and combat various complications that concern injuries, which have not completely recovered, such as excessive inflammation, ischemia disruption, wound, and infection scar.
Natural origin-based substances have unique qualities like great biocompatibility, economic efficiency, and low toxicity. With the aid of drugs, biomacromolecules, and cells, scientists have developed biopolymer-based wound dressings that start skin regeneration and quick healing, are haemostatic, cytocompatible, and have anti-inflammatory and antibacterial action.
Currently, dressings made from natural and synthetic sources are receiving more attention. Plant extracts have been examined successfully in injectable forms for adult stem cell therapies, and they have been placed into dressings and proven to be useful in skin regeneration. Proteolytic enzymes control a wide range of metabolic processes, including immunological response and cell division. The first enzymatic therapy used to heal chronic wounds was exogenous caspase.
The biopolymers and bioactive substances that are employed in wound dressings come from natural sources, such as microbial, plant, and animal sources. Biopolymers such as chitosan, cellulose, hyaluronic acid, alginate, elastin, dextran, fibrin, pectin, gelatin, collagen, and fibronectin are frequently utilised to make dressings based on the needs and type of lesion.
One of the primary trend factors projected to drive the advance wound dressing market growth is the increasing use of advanced wound products due to the rising number of trauma and burn cases worldwide.
Companies in the advanced wound dressing industry use product innovation and acquisition as their primary strategies to expand both their market share and product sales.
The global market is likely to show high growth over the coming years at a CAGR of 3.4% and reach a global market size of US$ 8.8 Billion by 2033.
“Novel Therapeutic Regimens, and Emergence of Standardized Wound Management Guidelines”
The development of more advanced and innovative therapeutic regimes for addressing chronic wounds is a crucial necessity. Bioengineered skin grafts, nanotherapeutics, 3D bioprinting-based techniques, and stem cell therapy are recent advancements in advanced wound care technologies that aim to improve therapeutic outcomes with an emphasis on skin regeneration with minimal side effects.
Modern wound dressings (hydrogels), topical medication and growth factor delivery, ultrasound, electrotherapy, vacuum-assisted closure, exosome, and auto/allograft and xenograft based approach are some of the treatment strategies being used for wound healing in recent years based on wound characteristics and inherent regenerative potential. These techniques now include hyperbaric oxygen therapy.
Over the past three decades, polymeric film-based dressings have been used with progressively better application and design. Transparent and semipermeable film-based dressings are simple to shape to the surface of the wound. High vapour transmission rates, bacterial impermeability, and the capacity for automated scab removal are all benefits of film-based dressings.
For surgical wounds, abrasions, burns, infected wounds, and superficial wounds, polymeric films made from a variety of natural and synthetic polymers have been used as dressings. There are currently a number of FDA-approved film-based dressings on the market, including OpsiteTM, TegadermTM, BiooclusiveTM, Hydrofilm/HydrofilmTM, etc., with varied degrees of permeability, adhesiveness, and ease of integration.
The formalisation of practise standards, improvement of clinical treatment recommendations, standardisation of product usage, and shortening of registration & licencing periods for advanced wound management products are anticipated benefits of streamlining and improving regulatory processes in emerging nations like Brazil and Mexico.
This would assist businesses in ensuring that their products adhere to the quality, safety, and hygiene standards set by nodal regulatory authorities like the U.S. CDC, Australian TGA, and U.K. NHS, among others.
These factors are set to present opportunistic growth prospects for the global market, throughout the forecast period.
“High Cost and Limitations of Available Treatment Options”
Effective and high-quality wound healing is currently very difficult and expensive for researchers and physicians. This can be supported by the expanding global market for wound care products, which, according to an updated 2020 Compendium of Estimates on the Human Wound and Its Burden: Adv Wound Care (2021) will grow from its estimated size of USD12 billion in 2020 to USD18.7 billion by 2027.
Stem cell-based therapies using various stem cell types, including induced pluripotent stem cells (IPSCs) and mesenchymal stem cells, have gained much attention as a part of stem cell-based regenerative medicine and have been tested in preclinical and clinical trials. These therapies are among the newer forms of treatment.
The therapeutic efficacy of stem cell-based therapy is, however, constrained by the low stem cell viability in the wound site following implantation/grafting as a result of a harsh inflammatory environment.
For the treatment of complete and partial depth burns, diabetic ulcers, and chronic wounds, a variety of commercialized dermo-epidermal cellular equivalents are available. Unfortunately, there remain certain drawbacks, such as the risk for tissue rejection and the expensive cost of epidermal-dermal cellular skin substitutes. To solve these difficulties, additional research studies and technical advancements are required.
The heterogeneous makeup of various chronic wounds presents another difficulty by limiting the ability of nanomaterials to regenerate and engage in self-healing processes. In addition to these challenges, the expense of nanoformulations is another limitation to the use of nanomaterials for wound healing in clinical settings.
Current therapeutic modalities each pose some limitations, and are thus expected to impede market expansion over the projected years.
Why is the U.S. Market Booming?
“Developed Healthcare Infrastructure, and High Prevalence of Disease”
The U.S. accounted for around 94.0% market share in the North America market in 2022.
The market is set to expand within the U.S. due to factors, which include a large geriatric population requiring extended hospitalizations, increasing prevalence of wound and injuries, a high prevalence of diabetes, and technological innovations and new product launch activities. With rising healthcare expenditure and growing government support and reimbursement policies for products, the market is expected to expand within the country, throughout the forecast period.
Will Germany Be a Lucrative Market for Advanced Wound Dressing?
“Growing Awareness Initiatives on Wound Care and Its Impact on Health Systems”
Germany held around 25.5% market share of the Europe market in 2022.
Working group "Advanced Wound Care Sector Group" is a part of "Voice of the Medical Technology Industry in Europe" (Eucomed). This organisation collaborates closely with the European Wound Management Association, the clinical voice of wound management. Their objective is to improve the quality of wound and patient safety. They also aim to bring attention to the major impact that wounds have on both patients and medical workers.
Such associations are set to promote the global market within Germany.
How is China Emerging as a Prominent Market?
“Increasing Domestic Sales of Wound Care Products and Rising Disposable Income”
China held a market share of about 45.7% of the East Asia market in 2022.
Due to rising domestic demand and declining export markets, the market in China is transitioning from an export-focused sector to a domestic sales-focused industry. Both the percentage of domestic sales and the number of export-focused manufacturers entering the domestic market have increased.
The growth potential of the advanced wound care dressing market is anticipated to rise in China due to the rise in disposable income and medical doctors’ awareness of the advantages of these dressings.
Which Product is Driving Demand within the Global Market?
“Efficacy and Versatility of Foam Dressings”
The foam dressings segment held around 27.20% share of the total market in 2022.
Foam dressings are frequently used on wounds with moderate to severe exudate to maintain a moist wound environment. They are excellent for sites with increased friction or bony prominences because of their versatility and cushioning effect. Foam dressings can be used with other agents, such as enzymatic debriders, and there are newer foams that contain ionic silver, a broad-spectrum antibacterial.
Over the course of the projection year, these benefits will support the segment's growth.
Which Indication is Largely of Concern within the Global Market?
“Chronic Wound Management as a Field of Specialty”
Chronic ulcers held around 69.1% share of the total market in 2022.
Vascular ulcers (such as venous and arterial ulcers), diabetic ulcers, and pressure ulcers are three different types of chronic ulcers. Providers frequently employ cutting-edge therapies, such as negative pressure wound therapy, engineered skin, growth factors, and extracellular matrices, in the care of chronic wounds, which has grown into a separate specialty. This provides traction towards care within the chronic ulcers segment, thus propelling market share over the forecast period.
Which Distribution Channel Promotes Sales within the Global Market?
“Rising Surgical Procedures and High Prevalence of Chronic Diseases”
Institutional sales hold a share of about 70.3% in 2022, globally.
Wounds from surgical sites are frequently treated with advanced wound care dressings. An increase in people with venous leg ulcers and diabetic foot ulcers is responsible for the segment's growth. The sector is also expanding as a result of a rise in surgical wound cases brought on by an increase in surgical procedures.
Through mergers and acquisitions, product development programmes, and the introduction of new products, major market players grow their businesses in a number of geographic areas. Product releases, player growth into growing markets, and complementary acquisitions in both old and new locations are how the sector generates its revenue.
Some key instances of development include:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the advanced wound dressing market, which are available in the full report.
|
Attribute |
Details |
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2015-2022 |
|
Market Analysis |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Indication:
Distribution Channel:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 6.1 Billion in 2022.
Sales of the market are set to witness growth at a CAGR of 3.4% and be valued at around US$ 8.8 Billion by 2033.
Demand for the global market increased at a 3.4% CAGR from 2015 to 2022.
The U.S., Germany, China, U.K., and Russia account for most demand within the market, currently holding around 60.6% market share.
The U.S. accounts for around 94.0% share of the North American market in 2022.
Latin America accounts for around 3.9% share of the global market in 2022.
The China market held a share of about 45.7% in the East Asia advanced wound dressing market in 2022.
The Germany advanced wound dressing market is set to expand at 2.5% CAGR over the forecast period.
The Brazil advanced wound dressing market is expected to grow at a 3.8% CAGR during the forecast period.
The advanced wound dressing market in India is set to expand at a 6.2% CAGR over the forecast period.
